Media Summary: If you or a loved one has a serious or life-threatening disease and current treatment is not working or there are no approved ... FDA Drug Info Rounds pharmacists discuss the requirements that must be met before FDA This webinar provided a comprehensive understanding of the

Could An Expanded Access Program - Detailed Analysis & Overview

If you or a loved one has a serious or life-threatening disease and current treatment is not working or there are no approved ... FDA Drug Info Rounds pharmacists discuss the requirements that must be met before FDA This webinar provided a comprehensive understanding of the The first of our series of educational videos on pre-approval Have you or a loved one been diagnosed with a life-threatening illness with no current treatment options? Learn how J. Paul Phillips provides an overview of the FDA's

This is the third webinar in this series from the IAA Clinical Trials team. It focuses on the FDA's On Rare Disease Day 2017 at Capitol Hill, we spoke with Jaswinder Khera, US Managing Director of WEP Clinical who provided ...

Photo Gallery

Could an Expanded Access Program (EAP) be Right for You?
Expanded Access
Expanded Access Programs (Compassionate Use)
What is Expanded Access?
Expanded Access Part 1: Introduction
Patients Matter: What is Expanded Access?
Expanded Access to Investigational Drugs for Treatment Use - Questions and Answers
Early Access Programs - All You Need To Know | myTomorrows
Expanded Access To New Medicines:  How it Works in the U.S.
How Do Expanded Access Programs Work?
Overview of FDA's Expanded Access Program (13/14) REdI 2017
Clinical Trials Webinar 3: Expanded Access Programs (EAP)
View Detailed Profile
Could an Expanded Access Program (EAP) be Right for You?

Could an Expanded Access Program (EAP) be Right for You?

If you or a loved one has a serious or life-threatening disease and current treatment is not working or there are no approved ...

Expanded Access

Expanded Access

FDA Drug Info Rounds pharmacists discuss the requirements that must be met before FDA

Expanded Access Programs (Compassionate Use)

Expanded Access Programs (Compassionate Use)

Expanded Access Programs

What is Expanded Access?

What is Expanded Access?

This week's briefing focuses on

Expanded Access Part 1: Introduction

Expanded Access Part 1: Introduction

What is

Patients Matter: What is Expanded Access?

Patients Matter: What is Expanded Access?

This segment discusses FDA's

Expanded Access to Investigational Drugs for Treatment Use - Questions and Answers

Expanded Access to Investigational Drugs for Treatment Use - Questions and Answers

This webinar provided a comprehensive understanding of the

Early Access Programs - All You Need To Know | myTomorrows

Early Access Programs - All You Need To Know | myTomorrows

What is an

Expanded Access To New Medicines:  How it Works in the U.S.

Expanded Access To New Medicines: How it Works in the U.S.

The first of our series of educational videos on pre-approval

How Do Expanded Access Programs Work?

How Do Expanded Access Programs Work?

Have you or a loved one been diagnosed with a life-threatening illness with no current treatment options? Learn how

Overview of FDA's Expanded Access Program (13/14) REdI 2017

Overview of FDA's Expanded Access Program (13/14) REdI 2017

J. Paul Phillips provides an overview of the FDA's

Clinical Trials Webinar 3: Expanded Access Programs (EAP)

Clinical Trials Webinar 3: Expanded Access Programs (EAP)

This is the third webinar in this series from the IAA Clinical Trials team. It focuses on the FDA's

WEP Clinical - Expanded Access Programs

WEP Clinical - Expanded Access Programs

On Rare Disease Day 2017 at Capitol Hill, we spoke with Jaswinder Khera, US Managing Director of WEP Clinical who provided ...